Genetic, Preclinical, and Clinical Evidence Supports SGK1 Inhibition in Heart Failure.

Pradhananga S, Srinivasan D, Campeau E, Vidal M, Labit D, Frias Boligan K, Brkovic A, Truex PF, Odink D, Gamazon ER, Shah R, Sehnert A, Das S

Open source

DOI
10.1016/j.jchf.2026.103304
Published
2026 Sep 4
Container
JACC. Heart failure
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.jchf.2026.103304,
  title = {Genetic, Preclinical, and Clinical Evidence Supports SGK1 Inhibition in Heart Failure.},
  author = {Pradhananga S and Srinivasan D and Campeau E and Vidal M and Labit D and Frias Boligan K and Brkovic A and Truex PF and Odink D and Gamazon ER and Shah R and Sehnert A and Das S},
  year = {2026},
  journal = {JACC. Heart failure},
  doi = {10.1016/j.jchf.2026.103304},
  url = {https://doi.org/10.1016/j.jchf.2026.103304}
}

RIS

TY  - JOUR
TI  - Genetic, Preclinical, and Clinical Evidence Supports SGK1 Inhibition in Heart Failure.
AU  - Pradhananga S
AU  - Srinivasan D
AU  - Campeau E
AU  - Vidal M
AU  - Labit D
AU  - Frias Boligan K
AU  - Brkovic A
AU  - Truex PF
AU  - Odink D
AU  - Gamazon ER
AU  - Shah R
AU  - Sehnert A
AU  - Das S
PY  - 2026
JO  - JACC. Heart failure
DO  - 10.1016/j.jchf.2026.103304
UR  - https://doi.org/10.1016/j.jchf.2026.103304
ER  - 

APA

S, P., D, S., E, C., M, V., D, L., K, F. B., A, B., PF, T., D, O., ER, G., R, S., A, S., & S, D. (2026). Genetic, Preclinical, and Clinical Evidence Supports SGK1 Inhibition in Heart Failure.. JACC. Heart failure. https://doi.org/10.1016/j.jchf.2026.103304

Source records